LifeMD Inc (NAS:LFMD)

$ 4.91 -0.08 (-1.6%) Market Cap: 212.66 Mil Enterprise Value: 201.98 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 76/100

Q3 2024 LifeMD Inc Earnings Call Transcript
Nov 07, 2024

$5.13 (+1.38%)

Earnings
Q2 2024 LifeMD Inc Earnings Call Transcript
Aug 07, 2024

$5.37 (-7.17%)

Earnings
Q1 2024 LifeMD Inc Earnings Call Transcript
May 08, 2024

$12.33 (-0.40%)

Earnings
Q4 2023 LifeMD Inc Earnings Call Transcript
Mar 11, 2024

$7.95 (-0.62%)

Earnings
Q3 2023 LifeMD Inc Earnings Call Transcript
Nov 08, 2023

$7.16 (-0.56%)

Earnings
Q2 2023 LifeMD Inc Earnings Call Transcript
Aug 09, 2023

$3.66 (-2.40%)

Earnings
Q1 2023 LifeMD Inc Earnings Call Transcript
May 12, 2023

$1.83

Earnings
LifeMD Inc at Sidoti & Company May Micro-Cap Virtual Conference Transcript
May 10, 2023
Q4 2022 LifeMD Inc Earnings Call Transcript
Mar 22, 2023

$1.4 (+19.66%)

Earnings
Q3 2022 LifeMD Inc Earnings Call Transcript
Nov 10, 2022

$2.08 (+3.48%)

Earnings
Q2 2022 LifeMD Inc Earnings Call Transcript
Aug 11, 2022

$3.15 (+7.51%)

Earnings
Q1 2022 LifeMD Inc Earnings Call Transcript
May 13, 2022

$2.11 (+8.76%)

Earnings
Q4 2021 LifeMD Inc Earnings Call Transcript
Mar 07, 2022

$3.21 (-0.31%)

Earnings
LifeMD Inc Analyst and Investor Day (Virtual) Transcript
Feb 22, 2022
LifeMD Inc at Issuer Direct Winter Wonderland Best Ideas Investor Conference (Virtual) Transcript
Feb 09, 2022
LifeMD Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 11, 2021
Q3 2021 LifeMD Inc Earnings Call Transcript
Nov 10, 2021

$5 (-0.40%)

Earnings
Q2 2021 LifeMD Inc Earnings Call Transcript
Aug 12, 2021

$9.11 (+4.71%)

Earnings
Q1 2021 LifeMD Inc Earnings Call Transcript
May 13, 2021

$6.51 (-5.38%)

Earnings
Q4 2020 LifeMD Inc Earnings Call Transcript
Mar 29, 2021

$18.87 (-1.92%)

Earnings
Q3 2020 Conversion Labs Inc Earnings Call Transcript
Nov 16, 2020

$5.87 (+6.34%)

Earnings
Q2 2020 Conversion Labs Inc Earnings Call Transcript
Aug 17, 2020

Earnings

Q1 2023 LifeMD Inc Earnings Call Transcript

May 12, 2023 / 12:30PM GMT

Release Date Price: $1.83

Transcript 10-Q

Operator

Good morning. Thank you for joining us today to discuss the results for LifeMD's First Quarter ended March 31, 2023. Joining the call today are Justin Schreiber, Chairman and Chief Executive Officer; and Marc Benathen, Chief Financial Officer of LifeMD.

Following management's prepared remarks, we will open the call for a question-and-answer session. I'd like to remind everyone that today's call is being hosted via webcast. And a recording will be made available via the link of today's press release, which is available in the Investor Relations section of the company's website.

Before we begin, I would like to remind everyone that during this call, the company will make a number of forward-looking statements, which are subject to numerous risks and uncertainties that may cause the company's actual results to differ materially from those projected. These risks and uncertainties are described in the company's 10-K and 10-Q filings and within other filings that LifeMD may make with the SEC from time to time. Forward-looking statements made during this call are based on current information

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.